7.4.2.0: Drugs for urinary frequency enuresis and incontinence

Part of chapter 7 Obstetrics, Gynaecology and Urinary-Tract Disorders, section 7.4 Drugs for genito-urinary disorders

High-level prescribing trends for Drugs for urinary frequency enuresis and incontinence (BNF section 7.4.2.0) across NHS Bath and North East Somerset, Swindon and Wiltshire Integrated Care Board for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Trends

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Darifenacin hydrobromide (0704020AC)
Duloxetine hydrochloride (0704020AA)
Fesoterodine fumarate (0704020AD)
Flavoxate hydrochloride (0704020G0)
Mirabegron (0704020AE)
Oxybutynin (0704020J0)
Propiverine hydrochloride (0704020P0)
Solifenacin (0704020AB)
Tolterodine (0704020N0)
Trospium chloride (0704020Z0)
Vibegron (0704020AF)

Download raw data

Download CSVs: all data on Drugs for urinary frequency enuresis and incontinence or data on Drugs for urinary frequency enuresis and incontinence by Sub-ICB Location.